本文選題：生物制藥產(chǎn)業(yè)　切入點(diǎn)：產(chǎn)業(yè)技術(shù)創(chuàng)新能力　出處：《昆明理工大學(xué)》2017年碩士論文

【摘要】：生物制藥產(chǎn)業(yè)是典型的高技術(shù)產(chǎn)業(yè),全國很多省區(qū)都將生物制藥產(chǎn)業(yè)作為支柱性產(chǎn)業(yè)或者戰(zhàn)略性新興產(chǎn)業(yè)來加以培育和發(fā)展。對生物制藥產(chǎn)業(yè)的培育和發(fā)展往往涉及到產(chǎn)業(yè)技術(shù)創(chuàng)新、產(chǎn)業(yè)變革,甚至社會體制的改革,單純的技術(shù)創(chuàng)新或者市場的培育成效甚微。由于生物制藥產(chǎn)業(yè)是新興的高技術(shù)高門檻行業(yè),并且對生物制藥的相關(guān)研究還處于探索階段,所以可供參考的文獻(xiàn)研究相對較少。縱觀目前國內(nèi)生物制藥技術(shù)創(chuàng)新的相關(guān)研究與文獻(xiàn),大多集中在產(chǎn)業(yè)技術(shù)創(chuàng)新戰(zhàn)略聯(lián)盟、產(chǎn)業(yè)技術(shù)創(chuàng)新管理模式、產(chǎn)業(yè)技術(shù)創(chuàng)新效率及其評價(jià)指標(biāo)體系、產(chǎn)業(yè)技術(shù)創(chuàng)新能力及其評價(jià)指標(biāo)體系、產(chǎn)業(yè)技術(shù)創(chuàng)新系統(tǒng)等方面,而生物制藥產(chǎn)業(yè)技術(shù)創(chuàng)新能力系統(tǒng)的涌現(xiàn)性方面的相關(guān)研究相對比較缺乏。云南省作為一個(gè)醫(yī)藥大省,具有得天獨(dú)厚的地理優(yōu)勢和資源優(yōu)勢,近年來云南生物制藥產(chǎn)業(yè)發(fā)展迅速,但與全國很多省份相比,存在較大差距。在未來相當(dāng)長一段時(shí)間內(nèi),如何快速提高云南生物制藥產(chǎn)業(yè)的技術(shù)創(chuàng)新能力和產(chǎn)業(yè)競爭力,帶動云南生物制藥產(chǎn)業(yè)的發(fā)展具有重要的現(xiàn)實(shí)意義。因此,筆者基于復(fù)雜適應(yīng)系統(tǒng)(CAS)理論和產(chǎn)業(yè)技術(shù)創(chuàng)新理論的視角,將云南生物制藥產(chǎn)業(yè)技術(shù)創(chuàng)新能力系統(tǒng)視為復(fù)雜適應(yīng)系統(tǒng),分析了該系統(tǒng)的構(gòu)成和運(yùn)行機(jī)制,在此基礎(chǔ)上,構(gòu)建了云南生物制藥產(chǎn)業(yè)技術(shù)創(chuàng)新能力系統(tǒng)概念模型和云南生物制藥產(chǎn)業(yè)技術(shù)創(chuàng)新能力系統(tǒng)涌現(xiàn)性度量模型。基于涌現(xiàn)理論,分析了云南生物制藥產(chǎn)業(yè)技術(shù)創(chuàng)新能力系統(tǒng)的涌現(xiàn)來源、涌現(xiàn)過程和涌現(xiàn)結(jié)果,構(gòu)建了云南生物制藥產(chǎn)業(yè)技術(shù)創(chuàng)新能力系統(tǒng)涌現(xiàn)性度量指標(biāo)體系,運(yùn)用主成分分析法對度量指標(biāo)體系提取主成分,獲得影響云南生物制藥產(chǎn)業(yè)技術(shù)創(chuàng)新能力系統(tǒng)涌現(xiàn)性的四種不同類型熵,并對云南生物制藥產(chǎn)業(yè)技術(shù)創(chuàng)新能力系統(tǒng)涌現(xiàn)的熵值進(jìn)行計(jì)算分析。
[Abstract]:The biopharmaceutical industry is a typical high-tech industry. Many provinces and regions in China have cultivated and developed the biopharmaceutical industry as a pillar industry or a strategic emerging industry. The cultivation and development of the biopharmaceutical industry often involves industrial technological innovation and industrial transformation. Even with the reform of the social system, pure technological innovation or the cultivation of the market, little has been achieved. Because the biopharmaceutical industry is a new high-tech and high-threshold industry, and the related research on biopharmaceuticals is still in the exploratory stage, Therefore, there is relatively little literature research for reference. At present, most of the relevant research and literature on biopharmaceutical technology innovation in China are concentrated in the strategic alliance of industrial technological innovation, the management mode of industrial technological innovation, Industrial technological innovation efficiency and its evaluation index system, industrial technological innovation ability and its evaluation index system, industrial technological innovation system, etc. However, the relative research on the emergence of the technological innovation ability system in the biopharmaceutical industry is relatively lacking. As a large pharmaceutical province, Yunnan Province has unique geographical and resource advantages. In recent years, the biopharmaceutical industry in Yunnan has developed rapidly, but compared with many provinces in China, there is a big gap. In a long period of time in the future, how to rapidly improve the technological innovation ability and industrial competitiveness of the biopharmaceutical industry in Yunnan Province, Therefore, based on the theory of complex adaptive system (CAS) and the theory of industrial technological innovation, it is of great practical significance to promote the development of biopharmaceutical industry in Yunnan. The technological innovation ability system of Yunnan biopharmaceutical industry is regarded as a complex adaptive system. The composition and operation mechanism of the system are analyzed. The concept model of Yunnan Biopharmaceutical Industry technological Innovation capability system and the Yunnan Biopharmaceutical Industry technological Innovation capability system emergence measure Model are constructed. This paper analyzes the origin, process and result of the emergence of Yunnan Biopharmaceutical Industry technological Innovation ability system, and constructs the emergent index system of Yunnan Biopharmaceutical Industry technological Innovation capability system. The principal component analysis was used to extract the principal components from the measurement index system, and four different types of entropy were obtained to influence the emergence of the technological innovation ability of Yunnan biopharmaceutical industry. The entropy of Yunnan biopharmaceutical industry technological innovation ability system is calculated and analyzed.
【學(xué)位授予單位】：昆明理工大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：F273.1;F426.72

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 李垣，汪應(yīng)洛;關(guān)于企業(yè)技術(shù)創(chuàng)新模式的探討[J];科學(xué)管理研究;1994年01期

2 張耀輝;產(chǎn)業(yè)創(chuàng)新:新經(jīng)濟(jì)下的產(chǎn)業(yè)升級模式[J];數(shù)量經(jīng)濟(jì)技術(shù)經(jīng)濟(jì)研究;2002年01期

3 吳友軍;產(chǎn)業(yè)技術(shù)創(chuàng)新能力評價(jià)指標(biāo)體系研究[J];商業(yè)研究;2004年11期

4 李榮平,李劍玲;產(chǎn)業(yè)技術(shù)創(chuàng)新能力評價(jià)方法研究[J];河北科技大學(xué)學(xué)報(bào);2003年01期

5 丁云龍,李玉剛;從技術(shù)創(chuàng)新角度看產(chǎn)業(yè)結(jié)構(gòu)升級模式[J];哈爾濱工業(yè)大學(xué)學(xué)報(bào)(社會科學(xué)版);2001年01期

6 張兵 ,曾珍香 ,李艷雙;基于CAS理論的企業(yè)可持續(xù)發(fā)展的動態(tài)支撐機(jī)制研究[J];科學(xué)學(xué)與科學(xué)技術(shù)管理;2004年01期

7 任錦鸞,顧培亮;基于復(fù)雜理論的創(chuàng)新系統(tǒng)研究[J];科學(xué)學(xué)研究;2002年04期

8 毛凱軍,田敏,許慶瑞;基于復(fù)雜系統(tǒng)理論的企業(yè)集群進(jìn)化動力研究[J];科研管理;2004年04期

9 李金洲;;我國生物醫(yī)藥產(chǎn)業(yè)可持續(xù)發(fā)展戰(zhàn)略研究[J];商業(yè)時(shí)代;2007年35期

10 苗東升;;論系統(tǒng)思維(六):重在把握系統(tǒng)的整體涌現(xiàn)性[J];系統(tǒng)科學(xué)學(xué)報(bào);2006年01期

相關(guān)重要報(bào)紙文章 前1條

1 金碚;;筑牢產(chǎn)業(yè)轉(zhuǎn)型發(fā)展的根基[N];經(jīng)濟(jì)日報(bào);2014年

相關(guān)博士學(xué)位論文 前1條

1 管順豐;產(chǎn)業(yè)創(chuàng)新管理理論研究與實(shí)證分析[D];武漢理工大學(xué);2007年

相關(guān)碩士學(xué)位論文 前1條

1 李海濤;產(chǎn)業(yè)技術(shù)創(chuàng)新能力綜合評價(jià)[D];蘇州大學(xué);2006年

，

本文編號：1680172